Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
116 | 3 | HEMATOLOGY//BONE MARROW TRANSPLANTATION//CELL & TISSUE ENGINEERING | 71918 |
79 | 2 | BONE MARROW TRANSPLANTATION//HEMATOLOGY//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 27434 |
6017 | 1 | ARA CTP//CYTOSINE ARABINOSIDE//URACIL ARABINOSIDE | 1573 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ARA CTP | authKW | 151831 | 1% | 63% | 12 |
2 | CYTOSINE ARABINOSIDE | authKW | 143144 | 3% | 15% | 47 |
3 | URACIL ARABINOSIDE | authKW | 83475 | 0% | 83% | 5 |
4 | ARA C | authKW | 60595 | 2% | 11% | 28 |
5 | POSTINDUCTION THERAPY | authKW | 60103 | 0% | 100% | 3 |
6 | 1 BETA D ARABINOFURANOSYLCYTOSINE | authKW | 43845 | 1% | 24% | 9 |
7 | FOSTEABINE | authKW | 40069 | 0% | 100% | 2 |
8 | CYTARABINE TRIPHOSPHATE | authKW | 36060 | 0% | 60% | 3 |
9 | CYTARABINE OCFOSFATE | authKW | 35612 | 0% | 44% | 4 |
10 | CYTARABINE | authKW | 31321 | 2% | 5% | 29 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 17022 | 54% | 0% | 846 |
2 | Hematology | 16076 | 31% | 0% | 486 |
3 | Medicine, General & Internal | 854 | 12% | 0% | 191 |
4 | Transplantation | 388 | 4% | 0% | 57 |
5 | Pharmacology & Pharmacy | 248 | 10% | 0% | 155 |
6 | Pediatrics | 175 | 5% | 0% | 73 |
7 | Immunology | 41 | 4% | 0% | 69 |
8 | Medicine, Research & Experimental | 6 | 2% | 0% | 32 |
9 | Medical Laboratory Technology | 1 | 0% | 0% | 6 |
10 | Pathology | 0 | 1% | 0% | 13 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CHILDRENS HAMATOL | 20034 | 0% | 100% | 1 |
2 | HLTH SCI MED IMMUNOL | 20034 | 0% | 100% | 1 |
3 | J ANESE RED CROSSNAKAMURA KU | 20034 | 0% | 100% | 1 |
4 | J PAOLI I CALMETTES BIOSTAT UNIT | 20034 | 0% | 100% | 1 |
5 | JOHN L MCCLELLAN CLIN MED SCI | 20034 | 0% | 100% | 1 |
6 | LEUKEMIA LYMPHOMA GRP | 20034 | 0% | 100% | 1 |
7 | MED DENT CLIN SERV HEMATOL UNIT | 20034 | 0% | 100% | 1 |
8 | MED NACL MEXICANO SEGURO SOCIAL | 20034 | 0% | 100% | 1 |
9 | NEW JERSEY MED PEDIATUNIV MED DENT NE | 20034 | 0% | 100% | 1 |
10 | PEDIAT PEDIAT ONCOL LGO A GEMELLI 8 | 20034 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | SEMINARS IN ONCOLOGY | 18232 | 4% | 1% | 69 |
2 | ONKOLOGIE | 12948 | 3% | 2% | 41 |
3 | CANCER TREATMENT REPORTS | 12394 | 2% | 2% | 37 |
4 | LEUKEMIA | 11948 | 4% | 1% | 68 |
5 | LEUKEMIA RESEARCH | 8788 | 3% | 1% | 52 |
6 | BLUT | 7649 | 1% | 2% | 19 |
7 | MEDICAL AND PEDIATRIC ONCOLOGY | 6696 | 2% | 1% | 29 |
8 | JOURNAL OF CLINICAL ONCOLOGY | 5062 | 4% | 0% | 65 |
9 | CANCER | 4859 | 5% | 0% | 83 |
10 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 4655 | 3% | 1% | 42 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ARA CTP | 151831 | 1% | 63% | 12 | Search ARA+CTP | Search ARA+CTP |
2 | CYTOSINE ARABINOSIDE | 143144 | 3% | 15% | 47 | Search CYTOSINE+ARABINOSIDE | Search CYTOSINE+ARABINOSIDE |
3 | URACIL ARABINOSIDE | 83475 | 0% | 83% | 5 | Search URACIL+ARABINOSIDE | Search URACIL+ARABINOSIDE |
4 | ARA C | 60595 | 2% | 11% | 28 | Search ARA+C | Search ARA+C |
5 | POSTINDUCTION THERAPY | 60103 | 0% | 100% | 3 | Search POSTINDUCTION+THERAPY | Search POSTINDUCTION+THERAPY |
6 | 1 BETA D ARABINOFURANOSYLCYTOSINE | 43845 | 1% | 24% | 9 | Search 1+BETA+D+ARABINOFURANOSYLCYTOSINE | Search 1+BETA+D+ARABINOFURANOSYLCYTOSINE |
7 | FOSTEABINE | 40069 | 0% | 100% | 2 | Search FOSTEABINE | Search FOSTEABINE |
8 | CYTARABINE TRIPHOSPHATE | 36060 | 0% | 60% | 3 | Search CYTARABINE+TRIPHOSPHATE | Search CYTARABINE+TRIPHOSPHATE |
9 | CYTARABINE OCFOSFATE | 35612 | 0% | 44% | 4 | Search CYTARABINE+OCFOSFATE | Search CYTARABINE+OCFOSFATE |
10 | CYTARABINE | 31321 | 2% | 5% | 29 | Search CYTARABINE | Search CYTARABINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |